Carta al Director
Controversia en cuanto al uso del icatibant como profilaxis en el angioedema
Controversy to use icatibant for prophylaxis in angioedema
a Servicio de Anestesiología y Reanimación, Centro de Referencia del angioedema mediado por bradiquinina, Hospices Civils de Lyon, Hospital Edouard Herriot, Lyon, Francia
b Clínica de Medicina Interna, Centro Nacional de Referencia del angioedema mediado por bradiquinina, Hospital Michallon, Grenoble, Francia
Leído
523
Vecesse ha leído el artículo
308
Total PDF
215
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 0 | 4 | 4 |
| 2025 10 | 0 | 7 | 7 |
| 2025 9 | 0 | 3 | 3 |
| 2025 8 | 0 | 4 | 4 |
| 2025 7 | 0 | 5 | 5 |
| 2025 6 | 0 | 5 | 5 |
| 2025 5 | 0 | 2 | 2 |
| 2025 4 | 0 | 1 | 1 |
| 2025 3 | 0 | 1 | 1 |
| 2025 2 | 0 | 2 | 2 |
| 2025 1 | 0 | 2 | 2 |
| 2024 12 | 0 | 7 | 7 |
| 2024 11 | 0 | 4 | 4 |
| 2024 10 | 0 | 4 | 4 |
| 2024 9 | 0 | 4 | 4 |
| 2024 8 | 0 | 1 | 1 |
| 2024 7 | 0 | 7 | 7 |
| 2024 6 | 0 | 4 | 4 |
| 2024 5 | 0 | 1 | 1 |
| 2024 3 | 1 | 8 | 9 |
| 2024 2 | 0 | 5 | 5 |
| 2024 1 | 0 | 2 | 2 |
| 2023 12 | 0 | 1 | 1 |
| 2023 11 | 0 | 1 | 1 |
| 2023 10 | 1 | 7 | 8 |
| 2023 9 | 0 | 16 | 16 |
| 2023 8 | 0 | 1 | 1 |
| 2023 7 | 0 | 7 | 7 |
| 2023 6 | 0 | 3 | 3 |
| 2023 4 | 0 | 3 | 3 |
| 2023 3 | 0 | 1 | 1 |
| 2022 1 | 0 | 1 | 1 |
| 2022 12 | 1 | 3 | 4 |
| 2022 9 | 0 | 5 | 5 |
| 2022 8 | 0 | 1 | 1 |
| 2022 7 | 2 | 0 | 2 |
| 2022 6 | 0 | 1 | 1 |
| 2022 5 | 0 | 1 | 1 |
| 2022 3 | 1 | 2 | 3 |
| 2021 1 | 0 | 1 | 1 |
| 2021 12 | 0 | 2 | 2 |
| 2021 10 | 0 | 1 | 1 |
| 2021 7 | 0 | 1 | 1 |
| 2021 4 | 0 | 1 | 1 |
| 2021 3 | 0 | 14 | 14 |
| 2021 2 | 0 | 1 | 1 |
| 2020 11 | 0 | 1 | 1 |
| 2020 5 | 0 | 3 | 3 |
| 2020 4 | 0 | 2 | 2 |
| 2020 3 | 0 | 4 | 4 |
| 2020 2 | 0 | 6 | 6 |
| 2020 1 | 0 | 3 | 3 |
| 2019 12 | 0 | 1 | 1 |
| 2019 10 | 1 | 1 | 2 |
| 2019 9 | 0 | 7 | 7 |
| 2019 8 | 0 | 5 | 5 |
| 2019 7 | 0 | 2 | 2 |
| 2019 6 | 0 | 7 | 7 |
| 2019 5 | 2 | 10 | 12 |
| 2019 4 | 0 | 1 | 1 |
| 2019 3 | 0 | 1 | 1 |
| 2019 2 | 0 | 1 | 1 |
| 2018 12 | 0 | 1 | 1 |
| 2018 11 | 0 | 1 | 1 |
| 2018 10 | 0 | 6 | 6 |
| 2018 6 | 2 | 0 | 2 |
| 2017 10 | 1 | 0 | 1 |
| 2017 7 | 7 | 2 | 9 |
| 2017 6 | 7 | 1 | 8 |
| 2017 5 | 9 | 1 | 10 |
| 2017 4 | 14 | 1 | 15 |
| 2017 3 | 25 | 3 | 28 |
| 2017 2 | 26 | 2 | 28 |
| 2016 1 | 23 | 4 | 27 |
| 2016 12 | 27 | 11 | 38 |
| 2016 11 | 28 | 11 | 39 |
| 2016 10 | 3 | 6 | 9 |
| 2016 9 | 0 | 2 | 2 |
| 2016 8 | 0 | 1 | 1 |
| 2016 7 | 0 | 1 | 1 |
| 2016 6 | 0 | 2 | 2 |
| 2016 5 | 1 | 3 | 4 |
| 2016 4 | 0 | 4 | 4 |
| 2016 3 | 0 | 2 | 2 |
| 2016 2 | 3 | 7 | 10 |
| 2015 1 | 1 | 3 | 4 |
| 2015 12 | 1 | 3 | 4 |
| 2015 11 | 13 | 6 | 19 |
| 2015 10 | 15 | 11 | 26 |
Mostrar todo
